NCT04501666 · Interventional trial
Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)
Overall registry status Completed
Phase 3
Conditions Prurigo Nodularis
Delaware Valley sites
- Galderma Investigational Site · Philadelphia, PA · Philadelphia County
- Galderma Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory